Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $225.59M.
ENTERPRISE VALUE (EV)
$225.59M
Greenwich LifeSciences, Inc.
Market Cap
$231.77M
Enterprise Value (EV)
$225.59M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | $231.77M | $225.59M |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | $152.55M |
| InflaRx N.V. (IFRX)vs › | $232.72M | $66.34M |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | $235.27M |
| Vogenx Inc. (VOGX)vs › | $227.91M | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | $134.08M |
| Biodesix, Inc. (BDSX)vs › | $227.60M | $269.40M |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | $118.83M |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | $165.69M |
| Invivyd, Inc. (IVVD)vs › | $237.57M | $85.88M |
Market Cap
$231.77M
Total Debt
$0.00
Cash
$6.18M
Enterprise Value
$225.59M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
